A Comparison of injection force and dosage scale size between novoPen ® 3 and NovoPen® 4

Diabetes Technology and Therapeutics

Volumn 11, Issue 9, 2009, Pages 581-585

  Donsmark, Morten ^a   Herold, Lars ^b   Kristensen, Carsten Mølgård ^a  

^a NOVO NORDISK A S   (Denmark)

^b Designit Strategic Design Consultancy   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; EVALUATION; FORCE; INJECTION; PRIORITY JOURNAL; SIMULATION; SYRINGE;

CONFIDENCE INTERVALS; DIABETES MELLITUS; DRUG DELIVERY SYSTEMS; HUMANS; HYPOGLYCEMIC AGENTS; IMAGE PROCESSING, COMPUTER-ASSISTED; INJECTIONS; INSULIN; REGRESSION ANALYSIS; ROBOTICS;

EID: 70349306725     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2008.0142     Document Type: Article

References (26)

1. Diabetes Fact Sheet N8312. Geneva: World Health Organization, 2008.
2. Diabetes Atlas, 3rd ed. Brussels: International Diabetes Federation, 2006.
3. Wang Y, Mi J, Shan XY, Wang QJ, Ge KY: Is China facing an obesity epidemic and the consequences? The trends in obesity and chronic disease in China. Int J Obes (Lond) 2007; 31:177-188.
4. Lebovitz HE: Type 2 diabetes: an overview. Clin Chem 1999;45:1339-1345.
5. Bohannon NJ: Insulin delivery using pen devices. Simple-to-use tools may help young and old alike. Postgrad Med 1999;106(5):57-58, 61-64, 68.
6. Rissler J, Jørgensen C, Rye Hansen M, Hansen NA: Evaluation of the injection force dynamics of a modified prefilled insulin pen. Expert Opin Pharmacother 2008;9: 2217-2222.
7. Korytkowski M, Bell D, Jacobsen C, Suwannasari R; FlexPen Study Team: A multicenter randomized, open-label, comparative, two-period crossover trial of preference, efficacy and safety profiles of a prefilled, disposable pen and conventional vial=syringe for insulin injection in patients with type 1 or 2 diabetes mellitus. Clin Ther 2003;25:2836-2848.
8. Fong DS, Aiello L, Gardner TW, King GL: Diabetic reti-nopathy. Diabetes Care 2003;26:226-229.
9. Ziegler D, Gries FA, Spüler M, Lessmann F: The epidemiology of diabetic neuropathy. DiaCAN Multicenter Study Group. Diabet Med 1993;10(Suppl 2):82-6S.
10. Savas S, Koroglu BK, Koyuncuoglu HR, Uzar E, Celik H, Tamer NM: The effects of the diabetes related soft tissue hand lesions and the reduced hand strength on functional disability of hand in type 2 diabetic patients. Diabetes Res Clin Pract 2007;77:77-83.
11. Schady W, Abuaisha B, Boulton AJ: Observations on severe ulnar neuropathy in diabetes. J Diabetes Complications 1998;12:128-132.
12. Centers for Disease Control and Prevention: http:= = apps. nccd.cdc.gov=DDTSTRS=default.aspx (accessed December 12, 2008).
13. Shelmet J, Schwartz S, Cappleman J, Peterson G, Skovlund S, Lytzen L, Nicklasson L, Liang J, Lyness W; InnoLet Study Group: Preference and resource utilization in elderly patients: InnoLet versus vial/syringe. Diabetes Res Clin Pract 2004;63:27-35.
14. Da Costa SA: Coordinated approach to insulin transfer in the older type 2 client. J Diabetes Nurs 1997;1:123-126.
15. Kadiri A, Chraibi A, Marouan F, Ababou MR, el Guermai N, Wadjinny A, Kerfati A, Douiri M, Bensouda JD, Belkhadir J, Arvanitis Y: Comparison of NovoPen 3 and syringes/vials in the acceptance of insulin therapy in NIDDM patients with secondary failure to oral hypoglycaemic agents. Diabetes Res Clin Pract 1998;41:15-23.
16. Toraishi K, Yuizono Y, Nakamura N, Kato S, Aoki T, Ashida K, Sako Y: Force requirements and insulin delivery profiles of four injection devices. Diabetes Technol Ther 2005;7:629-635.
17. Asakura T, Seino H: Assessment of dose selection attributes with audible notification in insulin pen devices. Diabetes Technol Ther 2005;7:620-626.
18. Pfutzner A, Reimer T, Hohberg C, Frøkjaer LP, Jørgensen C: Prefilled insulin device with reduced injection force: patient perception and accuracy. Curr Med Res Opin 2008;24:2545-2549.
19. Clarke A, Spollett G: Dose accuracy and injection force dynamics of a novel disposable insulin pen. Expert Opin Drug Deliv 2007;4:165-174.
20. Ignaut DA, Opincar M, Lenox S: FlexPen® and KwikPen™ prefilled insulin devices: a laboratory evaluation of ergo-nomic and injection force characteristics. J Diabetes Sci Technol 2008;2:533-537.
21. Sommavilla B, Jørgensen C, Jensen Kh: Safety, simplicity and convenience of a modified prefilled insulin pen. Expert Opin Pharmacother 2008;9:2223-2232.
22. Sommavilla G: Comparative assessment of NovoPen® 4, a new insulin pen system, among present NovoPen® 3 users [abstract]. Diabetes 2006;55(Supp 1):A456.
23. Goker B, Gamba S, Erdsieck RJ, Gilbey S, Schober E, Lytzen L, Kolaczynski M: NovoPen® 4 offers superior performance, handling and acceptance compared with NovoPen® 3 in insulin-treated diabetes patients [abstract]. Diabetes Technol Ther 2005;7:379.
24. Arendt-Nielsen L, Egekvist H, Bjerring P: Pain following controlled cutaneous insertion of needles with different diameters. Somatosens Mot Res 2006;23:37-43.
25. Iwanaga M, Kamoi K: Patient perceptions of injection pain and anxiety: a comparison of NovoFine 32-gauge tip 6mm and Micro Fine Plus 31-gauge 5mm needles. Diabetes Technol Ther 2009;11:81-86.
26. Israel-Bultman H, Donsmark M, Kolaczynski M: NovoPen® 4 increases diabetes treatment satisfaction during insulin therapy: results of an observational study in the Netherlands [abstract 2102-PO]. Diabetes 2007;56(Suppl 1):A532.